Stay updated on Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.

Latest updates to the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page
- CheckyesterdayChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedUpdated site revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision stamp updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no changes to study content or functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedMinor site version update from v3.4.0 to v3.4.1 with no impact on study data, content, or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.